Држава: Аустралија
Језик: Енглески
Извор: Department of Health (Therapeutic Goods Administration)
amisulpride, Quantity: 200 mg
Southern Cross Pharma Pty Ltd
Amisulpride
Tablet, uncoated
Excipient Ingredients: sodium starch glycollate type A; lactose monohydrate; microcrystalline cellulose; hypromellose; magnesium stearate
Oral
90, 60, 30
(S4) Prescription Only Medicine
Amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.
Visual Identification: White, round, flat tablet, scored on one side with diameter 11.5 mm; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius
Registered
2016-01-29